Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-11-30

Clinical Trial Update: Celecoxib, Ibuprofen and the Antiplatelet Effect of Aspirin [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether celecoxib or ibuprofen alters aspirin's antiplatelet effect in ischemic heart disease and osteoarthritis. The study status is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aspirin (Aspirin)
  • CELEBREX (Celecoxib)
  • Ibuprofen (IBUPROFEN)

Snippet

Sponsor: University of Chieti | Conditions: Ischemic Heart Disease, Osteoarthritis | Phase 4 | Status: COMPLETED